Aurora Cannabis Inc. (NASDAQ:ACB – Get Free Report) was the target of a large growth in short interest in October. As of October 31st, there was short interest totalling 2,810,000 shares, a growth of 6.8% from the October 15th total of 2,630,000 shares. Based on an average daily trading volume, of 1,030,000 shares, the short-interest ratio is presently 2.7 days. Approximately 5.2% of the shares of the stock are sold short.
Institutional Investors Weigh In On Aurora Cannabis
Hedge funds have recently bought and sold shares of the business. Virtu Financial LLC bought a new stake in shares of Aurora Cannabis in the 1st quarter worth about $727,000. Headlands Technologies LLC raised its position in Aurora Cannabis by 98.8% during the second quarter. Headlands Technologies LLC now owns 74,988 shares of the company’s stock valued at $346,000 after purchasing an additional 37,269 shares during the period. TD Asset Management Inc purchased a new stake in Aurora Cannabis during the second quarter valued at approximately $255,000. Mackenzie Financial Corp bought a new stake in shares of Aurora Cannabis in the 2nd quarter valued at approximately $113,000. Finally, Baader Bank Aktiengesellschaft boosted its holdings in shares of Aurora Cannabis by 121.1% in the 2nd quarter. Baader Bank Aktiengesellschaft now owns 22,789 shares of the company’s stock worth $100,000 after purchasing an additional 12,481 shares during the period. Hedge funds and other institutional investors own 47.63% of the company’s stock.
Aurora Cannabis Trading Down 3.2 %
Aurora Cannabis stock opened at $4.20 on Friday. The company has a debt-to-equity ratio of 0.07, a current ratio of 3.83 and a quick ratio of 1.88. The firm’s 50 day moving average price is $5.52 and its 200-day moving average price is $5.88. Aurora Cannabis has a 1 year low of $2.84 and a 1 year high of $9.35. The stock has a market cap of $230.33 million, a P/E ratio of -5.53 and a beta of 1.87.
Aurora Cannabis Company Profile
Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.
Recommended Stories
- Five stocks we like better than Aurora Cannabis
- The 3 Best Blue-Chip Stocks to Buy Now
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
- Golden Cross Stocks: Pattern, Examples and Charts
- Freeport-McMoRan, Copper Demand Short-Term Pain, Long-Term Gain
- How to Use the MarketBeat Excel Dividend Calculator
- Time to Load Up on Home Builders?
Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.